NEWS

Medical equipment: domestically produced kills imported, there is a play in these four major areas!

  • Categories:Industry News
  • Author:
  • Origin:
  • Time of issue:2017-10-27
  • Views:0

(Summary description)Medical equipment:rapid growth is expected,and there is huge room for import substitution.From an industry perspective,my country’s medical device market has exceeded 300 billion yuan,making it the second largest market in the world.However,my country’s device consumption accounts for only 17%of the overall pharmaceutical market,only 40%of that of developed countries.With aging and the level of medical insurance payment It is estimated that in the next 5 years,there will be at least 5%of share improvement,corresponding to over 300 billion market expansion.

Medical equipment: domestically produced kills imported, there is a play in these four major areas!

(Summary description)Medical equipment:rapid growth is expected,and there is huge room for import substitution.From an industry perspective,my country’s medical device market has exceeded 300 billion yuan,making it the second largest market in the world.However,my country’s device consumption accounts for only 17%of the overall pharmaceutical market,only 40%of that of developed countries.With aging and the level of medical insurance payment It is estimated that in the next 5 years,there will be at least 5%of share improvement,corresponding to over 300 billion market expansion.

  • Categories:Industry News
  • Author:
  • Origin:
  • Time of issue:2017-10-27
  • Views:0
Information

  Medical equipment:rapid growth is expected,and there is huge room for import substitution.From an industry perspective,my country’s medical device market has exceeded 300 billion yuan,making it the second largest market in the world.However,my country’s device consumption accounts for only 17%of the overall pharmaceutical market,only 40%of that of developed countries.With aging and the level of medical insurance payment It is estimated that in the next 5 years,there will be at least 5%of share improvement,corresponding to over 300 billion market expansion.


  At the micro level,my country’s device manufacturers are“small and scattered”.More than 90%of them are small and medium-sized enterprises with a scale of less than 20 million yuan.Mid-to-high-end medical devices still rely on imports.Domestic companies are mainly responsible for relatively low value-added links in the industry chain.There is huge room for import substitution.


  The policy continues to catalyze,and dividends are released continuously.The premise of import substitution is the technological breakthrough of domestic equipment,and the core catalysis is the strong ice-breaking from the top to the bottom of the policy.


  In recent years,through policy combinations such as encouraging innovation,accelerating review,medical anti-corruption and supporting the purchase and use of domestic equipment,China has raised the level of innovative manufacturing of domestic brands on the one hand,and provided opportunities for domestic equipment to enter the market through reshaping the pattern.Cost-effective domestic equipment ushered in the spring of development.


  "Space+Technology+Mode"three-dimensional search for import substitution opportunities


  IVD field:Chemiluminescence has the most import substitution value.The sensitivity and automation of chemiluminescence are higher,and the technology trend of replacing enzyme-linked immunoassay is obvious.


  Foreign brands in the domestic market have occupied 90%-95%of the share by virtue of their technology and service advantages.Leading companies such as Antu Biology,New Industries,Mike Biology,Mindray Medical have achieved technological breakthroughs in the field of instruments and reagents and are more cost-effective."Superimpose"import substitution",conservatively estimate that the domestic brand chemiluminescence market will maintain a compound growth rate of 32.95%in the next five years,rapidly expanding and replacing.


  Medical imaging:DR(digital X-ray machine)ushered in new development opportunities.The domestic medical imaging market has long been highly monopolized by foreign capital.The total share of"GPS"in the domestic CT,MRI and ultrasound categories is 83.3%,85.7%and 69.4%respectively.


  With the increasing demand for equipment procurement in the grassroots market and private hospitals,as well as the increasing pressure of anti-corruption and fee control in tertiary hospitals,domestic high-end DRs are ushering in alternative opportunities.


  At present,Wandong Medical has achieved independent research and development of the core components of the full image chain,and is actively testing the modes of telemedicine and independent imaging centers.It is expected that the domestic DR market will maintain a growth of 10%-15%in the future,becoming the fastest growing radiographic imaging field.The largest product line.


  Cardiovascular and surgical instruments:imported replacement of pacemakers and endoscopic staplers is coming soon.The number of pacemakers implanted per million people in my country is less than 5%of that of developed countries.The market demand is limited by price and payment ability has not been effectively released.Currently,Lepu Medical’s domestic dual-chamber pacemakers are successfully launched and promoted.The pacemaker for cooperation has been approved,and the products jointly developed by Lifetech and Medtronic are also on the market soon.The domestic pacemaker industry is expected to replicate the import substitution road of coronary stents.


  Staplers are the largest category of surgical instruments.Among them,endoscopic staplers have formed a competitive pattern of"foreign capital dominated and domestic capital supplemented"due to higher technical requirements.At present,companies represented by Ningbo Bingkun,a subsidiary of Lepu,have quickly achieved technological breakthroughs.Start import substitution.


  Hemodialysis:The next blue ocean of chronic diseases,the layout of chain hemodialysis centers will accelerate.There are about 2 million patients with end-stage renal disease in my country,but the hemodialysis penetration rate is only 15%.With the advancement of critical illness medical insurance and the acceleration of the construction of hemodialysis centers,the market demand of 100 billion is expected to be released.


  At present,dialyzers and dialysis machines with high technical barriers are still dominated by foreign capital.Domestic brands of hemodialysis powder and dialysis concentrate have accounted for more than 90%,and domestic enterprises of dialysis tubing account for nearly 50%,and they are in the process of import substitution.At present,companies with strong synergy of resources such as Bolaite have built a full industrial chain model of"equipment+consumables+channels+services"for hemodialysis,in which equipment and services are coordinated to accelerate the realization of market demand.

Keyword:

Scan the QR code to read on your phone

Recommended news

23 years of training and development

The "Hongda" brand products produced by the group company have nine categories and dozens of varieties: infusion, blood transfusion equipment, injection equipment, puncture equipment, inspection or auxiliary equipment, anesthesia equipment, catheters, medical equipment, Cardiovascular intervention products, blood purification products, etc.

 江西洪达医疗器械集团有限公司

Scan and follow us

Copyright © 2021  Jiangxi Hongda Medical Equipment Group Ltd.  All rights reserved.        Jiangxi ICP Record No.11005027       Powered by www.300.cn